HALO logo
halo search icon
Anika Therapeutics, Inc.
Anika Therapeutics, Inc.
ANIK · NAS

Anika Therapeutics, Inc.

US$15.14

Price Arrow0.32 (2.16%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusEngulfing BullishEngulfing Bullish (Realtime)HALO AllHALO GrowthHALO Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Anika Therapeutics, Inc. Overview

ANIK Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ANIK

icon

Telephone

1.781.457.9000

icon

Address

32 Wiggins Avenue, Bedford, MA 01730

Description

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

ANIK Price Chart

Key Stats

Market Cap

US$197.19M

PE

148.80

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 7.87 - 16.24

Trade Value (12mth)

US$350,357.00

1 week

-0.6%

1 month

-1.46%

YTD

58.5%

1 year

26.56%

All time high

75.71

Key Fundamentals

EPS 3 yr Growth

-25.60%

EBITDA Margin

-4.70%

Operating Cashflow

$11m

Free Cash Flow Return

6.50%

ROIC

-5.80%

Interest Coverage

0.00

Quick Ratio

3.90

Other Data

Shares Outstanding (Fully Diluted)

14m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ANIK Announcements

Latest Announcements

DateAnnouncements
30 April 26
30 April 26
29 April 26
03 March 26
03 March 26

ANIK Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-5.64-3.83-0.76locklocklock
EPS (Fully Diluted)
$locklocklocklock-5.64-3.83-0.76locklocklock
Growth
%locklocklocklock-452.732.180.2locklocklock
PE
XlocklocklocklockN/A105148.8locklocklock
EV/EBITDA
XlocklocklocklockN/A318N/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Anika Therapeutics, Inc. (ANIK:NAS)?
Halo FAQ
The current share price of Anika Therapeutics, Inc. (ANIK:NAS) is USD$15.14.
What is the 52-week high share price for Anika Therapeutics, Inc. (ANIK:NAS)?
Halo FAQ
The 52-week high share price for Anika Therapeutics, Inc. (ANIK:NAS) is USD$16.24.
What is the 52-week low share price for Anika Therapeutics, Inc. (ANIK:NAS)?
Halo FAQ
The 52-week low share price for Anika Therapeutics, Inc. (ANIK:NAS) is USD$7.87.
What is the dividend yield for Anika Therapeutics, Inc. (ANIK:NAS)?
Halo FAQ
Anika Therapeutics, Inc. (ANIK:NAS) does not pay a dividend.
What was Anika Therapeutics, Inc. (ANIK:NAS) last dividend payment?
Halo FAQ
Anika Therapeutics, Inc. (ANIK:NAS) does not pay a dividend.
What is the franking level for Anika Therapeutics, Inc. (ANIK:NAS)?
Halo FAQ
Anika Therapeutics, Inc. (ANIK:NAS) has a franking level of 0.00%.
In which sector is Anika Therapeutics, Inc. (ANIK:NAS) classified?
Halo FAQ
Anika Therapeutics, Inc. (ANIK:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Anika Therapeutics, Inc. (ANIK:NAS)?
Halo FAQ
The current P/E ratio for Anika Therapeutics, Inc. (ANIK:NAS) is 148.80.

See beyond the curve.

One solution for research, investing and portfolio management.